Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 04-2019 | 03-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -3,327 | -2,197 | -5,135 | -5,135 |
| Depreciation Amortization | 254 | 135 | N/A | 0 |
| Accounts receivable | 80 | 113 | N/A | N/A |
| Other Working Capital | 143 | 107 | -450 | -450 |
| Other Operating Activity | 1,203 | 762 | 3,897 | 3,897 |
| Operating Cash Flow | $-1,647 | $-1,080 | $-1,688 | $-1,688 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -28 | -27 | N/A | 0 |
| Other Investing Activity | -10 | 0 | 0 | 0 |
| Investing Cash Flow | $-38 | $-27 | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 506 | 298 | N/A | N/A |
| Debt Repayment | -53 | -35 | N/A | N/A |
| Common Stock Issued | 742 | N/A | N/A | N/A |
| Other Financing Activity | -221 | -149 | 2,227 | 2,227 |
| Financing Cash Flow | $974 | $114 | $2,227 | $2,227 |
| Exchange Rate Effect | 4 | -1 | -7 | -7 |
| Beginning Cash Position | 1,199 | 1,199 | 0 | 0 |
| End Cash Position | 492 | 205 | 532 | 532 |
| Net Cash Flow | $-711 | $-994 | $532 | $532 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,647 | -1,080 | -1,688 | -1,688 |
| Capital Expenditure | -28 | -27 | N/A | N/A |
| Free Cash Flow | -1,675 | -1,107 | -1,688 | -1,688 |